iF488 Anti-Mouse/Human CD11b

Cat # Size Price Quantity
20120525 tests$70
201206100 tests$160

Product Details


CloneM1/70
ApplicationFC
ReactivityHuman, Mouse
FormatiF488
Target NameCD11b, ITGAM, integrin αM, CR3
IsotypeRat IgG2b
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 0.2% (w/v) BSA
Protein ConcentrationSupplied at a lot-specific concentration.
Storage and HandlingThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended UsageFor flow cytometric staining, it is recommended to use 5 uL of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application.
Excitation LaserBlue Laser (488 nm)

Background Information


CD11b, also known as integrin αM or ITGAM, is a type I transmembrane glycoprotein with a molecular weight of approximately 170 kDa under reducing conditions (165 kDa non-reducing) and contains 19 potential N-glycosylation sites. CD11b associates with CD18 (integrin β2) to form the heterodimeric integrin Mac-1 (CD11b/CD18), also referred to as αMβ2, CR3 (complement receptor 3), iC3b receptor, or Mo-1. The assembly of CD11b with CD18 is required for its surface expression and function. CD11b/CD18 is one of four integrins formed by pairing the β2 chain (CD18) with different α chains (CD11a–d). Mac-1 plays an essential role in cell adhesion, migration, and phagocytosis by binding to ligands including ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen. CD11b is highly expressed on NK cells, neutrophils, monocytes, macrophages, dendritic cells, and at lower levels on subsets of T and B lymphocytes. Through these interactions, CD11b/CD18 contributes to leukocyte trafficking, complement-mediated clearance, and modulation of innate and adaptive immune responses.

Data Sheets


iF488 Anti-Mouse/Human CD11b TDS

Related Products


iF488 Rat IgG2b Isotype control